Questionnaire | Lupus Quality of Life | SLE Quality of Life | Lupus Patient-Reported Outcome (LupusPRO) | Lupus Impact Tracker |
Country of development | UK | Singapore | USA | USA |
Number of items | 34 | 40 | 43 | 10 from LupusPRO |
Domains | Eight domains: physical health, emotional health, body image, pain, planning, fatigue, intimate relationships, burden to others | six domains: physical function, activities, symptoms, treatment, mood, self-image | Eight domains: symptoms, cognition, treatments, reproduction, physical health, pain/vitality, emotional health, body image, goals/aspirations, social support, coping, satisfaction with care | A unique dimension representing the impact of lupus |
Time to complete | <10 min | <10 min | 7–10 min | <5 min |
Questions | 5-point Likert scale (0–4) | 7-point Likert scale1–8 | 5-point Likert scale (0–4) | 5-point Likert scale (0–4) |
Recall period | 4 weeks | 1 week | 4 weeks | 4 weeks |
Scoring | Sum of items score by domain divided by 4 and multiplied by 10 | A summary score: sum of all items. Domain scores: sum of item responses by domain | Sum of items score by domain divided by 4 and multiplied by 10 | Sum of items score by domain divided by 4 and multiplied by 10 |
Interpretation | 0: worst possible QoL to 100: best possible QoL | Overall score from 40 to 280 (the higher the score, the lower the QoL), score range varies by domain | 0: worst possible QoL to 100: best possible QoL | 0: no impact of lupus to 100: highest possible impact of lupus |
Minimal clinically important difference | 3–7 (depends on domain) | An average increase of 25 points has been described in patients reporting an improvement in their clinical condition | An increase in score of between 3 and 8 points, depending on the domain, was noted in patients presenting an improvement in their activity criteria | A mean improvement of 8 points was described in SRI-4 responders. A mean improvement of −4.2 points was noted in patients reporting an improvement in their clinical condition |
QoL, quality of life.